Labeled for this condition
Medicines for heart failure
37 medicines have an FDA label indicated for heart failure; 33 are listed from generic labelers and 2 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for heart failure?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Metoprolol | Toprol, Kapspargo, Lopressor | 74 labelers | $0.085 per tablet 100 mg tablet | No | A presentation being discontinued | 39 |
| Lisinopril | Zestril, Qbrelis | 36 labelers | $0.0254 per tablet 20 mg tablet | Yes | No current entry | 28 |
| Furosemide | Lasix, Furoscix | 52 labelers | $0.490 per mL 20 mg/2 mL vial | No | In shortage | 8 |
| Carvedilol | Coreg | 41 labelers | $0.0179 per tablet 6.25 mg tablet | No | No current entry | 22 |
| Spironolactone | Aldactone, Carospir | 38 labelers | $0.0426 per tablet 25 mg tablet | No | A presentation being discontinued | 6 |
| Hydrochlorothiazide | Inzirqo | 43 labelers | $0.0115 per tablet 25 mg tablet | No | A presentation being discontinued | 7 |
| Valsartan | Diovan, Prexxartan | 34 labelers | $0.0963 per tablet 40 mg tablet | Yes | A presentation being discontinued | 58 |
| Bumetanide | Bumex, Enbumyst | 36 labelers | $0.108 per tablet 1 mg tablet | Yes | Resolved | 4 |
| Nitroglycerin | Nitrostat, Nitro-Dur, Nitrolingual | 31 labelers | $0.127 per tablet 0.4 mg tablet sl | No | A presentation being discontinued | 13 |
| Enalapril | Vasotec, Epaned | 28 labelers | $0.0664 per tablet 10 mg tablet | Yes | No current entry | 17 |
| Chlorthalidone | Hemiclor, Thalitone | 36 labelers | $0.0743 per tablet 25 mg tablet | No | No current entry | 5 |
| Sacubitril and valsartan | Entresto | 27 labelers | $0.533 per unit 49-51 mg | Yes | No current entry | 0 |
| Metolazone | none listed | 19 labelers | $0.233 per tablet 2.5 mg tablet | No | No current entry | 0 |
| Torsemide | Soaanz | 20 labelers | $0.0636 per tablet 20 mg tablet | No | No current entry | 2 |
| Digoxin | Lanoxin | 26 labelers | $0.133 per tablet 125 mcg tablet | No | No current entry | 4 |
| Dapagliflozin | Farxiga | 22 labelers | $0.184 per tablet 10 mg tablet | No | No current entry | 0 |
| Captopril | none listed | 13 labelers | $0.228 per tablet 12.5 mg tablet | Yes | No current entry | 5 |
| Candesartan | Atacand | 8 labelers | $0.478 per tablet 16 mg tablet | Yes | No current entry | 9 |
| Milrinone | none listed | 13 labelers | n/a | No | No current entry | 4 |
| Dapagliflozin and metformin | Xigduo | 8 labelers | $0.720 per tablet 10-1,000 mg tablet | Yes | No current entry | 2 |
| Quinapril | none listed | 9 labelers | n/a | Yes | In shortage | 7 |
| Ivabradine | Corlanor | 11 labelers | $0.761 per tablet 5 mg tablet | No | A presentation being discontinued | 2 |
| Sodium nitroprusside | Nipride | 12 labelers | n/a | Yes | No current entry | 0 |
| Eplerenone | Inspra | 9 labelers | $0.308 per tablet 25 mg tablet | No | No current entry | 0 |
| Fosinopril | none listed | 7 labelers | $0.154 per tablet 10 mg tablet | Yes | No current entry | 3 |
| Indapamide | none listed | 8 labelers | $0.109 per tablet 1.25 mg tablet | No | No current entry | 0 |
| Ethacrynic acid | Edecrin | 10 labelers | $0.807 per tablet 25 mg tablet | No | No current entry | 2 |
| Hydrochlorothiazide and spironolactone | none listed | 6 labelers | $0.483 per tablet 25-25 tablet | No | No current entry | 0 |
| Empagliflozin | Jardiance | none listed | $11.19 per tablet 10 mg tablet | No | No current entry | 2 |
| Chlorothiazide | Diuril | 5 labelers | n/a | No | A presentation being discontinued | 0 |
| Triamterene | Dyrenium | 3 labelers | $5.98 per capsule 50 mg capsule | Yes | No current entry | 0 |
| Hydralazine and isosorbide dinitrate | Bidil | 3 labelers | $0.714 per tablet 20-37.5 mg tablet | No | No current entry | 0 |
| Amiloride | none listed | 2 labelers | $0.190 per tablet 5 mg tablet | Yes | No current entry | 0 |
| Vericiguat | Verquvo | none listed | $22.72 per tablet 10 mg tablet | Yes | No current entry | 0 |
| Sotagliflozin | Inpefa | none listed | $20.37 per tablet 200 mg tablet | No | No current entry | 0 |
| Amiloride and hydrochlorothiazide | none listed | 1 labeler | $0.450 per tablet 5-50 mg tablet | Yes | No current entry | 0 |
| Vutrisiran | Amvuttra | none listed | n/a | No | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price